Creative Capital Management Investments’s Healthpeak Properties DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.49K Hold
210
– – ﹤0.01% 443
2026
Q1
$3.45K Hold
210
– – ﹤0.01% 251
2025
Q4
$3.38K Hold
210
– – ﹤0.01% 255
2025
Q3
$4.02K Hold
210
– – ﹤0.01% 228
2025
Q2
$3.68K Hold
210
– – ﹤0.01% 263
2025
Q1
$4.25K Hold
210
– – ﹤0.01% 205
2024
Q4
$4.26K Hold
210
– – ﹤0.01% 219
2024
Q3
$4.8K Hold
210
– – ﹤0.01% 192
2024
Q2
$4.12K Hold
210
– – ﹤0.01% 193
2024
Q1
$3.94K Hold
210
– – ﹤0.01% 181
2023
Q4
$4.16K Hold
210
– – ﹤0.01% 182
2023
Q3
$3.86K Hold
210
– – ﹤0.01% 191
2023
Q2
$4.22K Hold
210
– – ﹤0.01% 176
2023
Q1
$4.61K Hold
210
– – ﹤0.01% 188
2022
Q4
$5K Buy
+210
New +$5.1K ﹤0.01% 142

Other funds holding DOC

Creative Capital Management Investments's DOC Position: Q2 2026 in Review

Creative Capital Management Investments held its Healthpeak Properties (DOC) position steady in Q2 2026 at 210 shares worth $4.49K. The position accounts for ﹤0.01% of the portfolio, ranked #443.

Creative Capital Management Investments first reported a position in DOC in Q4 2022 and has held it in 15 quarters since. The position peaked at $5K in Q4 2022. 764 funds tracked by Wall St. Rank hold DOC as of Q2 2026.

  • Creative Capital Management Investments held 210 shares of Healthpeak Properties worth $4.49K as of Q2 2026.
  • Creative Capital Management Investments left its Healthpeak Properties share count unchanged in Q2 2026.
  • Healthpeak Properties made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #443 holding.
  • Creative Capital Management Investments first reported a position in Healthpeak Properties in Q4 2022 and has held it in 15 quarters since.
  • Creative Capital Management Investments's Healthpeak Properties position peaked at $5K in Q4 2022.
  • 764 funds tracked by Wall St. Rank held Healthpeak Properties as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.